enow.com Web Search

Search results

1. Results from the WOW.Com Content Network

2. Management of Parkinson's disease - Wikipedia

   en.wikipedia.org/wiki/Management_of_Parkinson's...

   In the management of Parkinson's disease, due to the chronic nature of Parkinson's disease (PD), a broad-based program is needed that includes patient and family education, support-group services, general wellness maintenance, exercise, and nutrition. At present, no cure for the disease is known, but medications or surgery can provide relief ...

3. Trihexyphenidyl - Wikipedia

   en.wikipedia.org/wiki/Trihexyphenidyl

   Trihexyphenidyl (THP, benzhexol, trihex, marketed as Artane and others) is an antispasmodic drug used to treat stiffness, tremors, spasms, and poor muscle control. It is an agent of the antimuscarinic class and is often used in management of Parkinson's disease. It was approved by the FDA for the treatment of Parkinson's in the US in 2003. [2] [3]

4. Bornaprine - Wikipedia

   en.wikipedia.org/wiki/Bornaprine

   Bornaprine Pathway. Bornaprine is an antimuscarinic agent that nonselectively antagonizes muscarinic acetylcholine receptors, M1 and M2. [8] Bornaprine has been characterized as a very potent anticholinergic medication and further clinical trials have indicated its effectiveness at treating parkinsonian tremors.

5. Parkinson's disease - Wikipedia

   en.wikipedia.org/wiki/Parkinson's_disease

   Parkinson's typically manifests in individuals over 60, with about one percent affected. In those younger than 50, it is termed "early-onset PD". No cure for Parkinson's is known, and treatment focuses on alleviating symptoms. Initial treatment typically includes L-DOPA, MAO-B inhibitors, or dopamine agonists.

6. Novel drug molecule that helps recycle mitochondria may help ...

   www.aol.com/novel-drug-molecule-helps-recycle...

   Researchers have found that a novel drug molecule may fight the development of early-onset Parkinson’s disease in younger people. The new compound, BIO-2007817, is from the family of ...

7. Catechol-O-methyltransferase inhibitor - Wikipedia

   en.wikipedia.org/wiki/Catechol-O-methyltransfer...

   COMT inhibitors are indicated for the treatment of Parkinson's disease in combination with levodopa and an aromatic L-amino acid decarboxylase inhibitor (e.g. carbidopa or benserazide). The therapeutic benefit of using a COMT inhibitor is based on its ability to prevent the methylation of levodopa to 3- O -methyldopa , thus increasing the ...